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Cell function and survival are controlled by intracellular signals, and modulated by
surrounding cells and the extracellular environment. Connexin channels participate in
these processes by mediating cell-to-cell communication. In bone cells, gap junction
channels were detected in the early 1970s, and are present among bone resorbing
osteoclasts, bone forming osteoblasts, and osteocytes - mature osteoblasts embedded
in the mineralized matrix. These channels are composed mainly by Cx43, although the
expression of other connexins (45, 46, and 37) has also been reported. It is now believed
that undocked Cx43 hemichannels (connexons) formed in unopposed cell membranes
facing the extracellular environment participate in the interaction of bone cells with
the extracellular environment, and in their communication with neighboring cells. Thus,
we and others demonstrated the presence of active hemichannels in osteoblastic and
osteocytic cells. These hemichannels open in response to pharmacological and mechanical
stimulation. In particular, preservation of the viability of osteoblasts and osteocytes by
the anti-osteoporotic drugs bisphosphonates depends on Cx43 expression in vitro and
in vivo, and is mediated by undocked hemichannels. Cx43 hemichannels are also required
for the release of prostaglandins and ATP by osteocytes, and for cell survival induced by
mechanical stimulation in vitro. Moreover, they are required for the anti-apoptotic effect of
parathyroid hormone in osteoblastic cells. This review summarizes the current knowledge
on the presence and function of undocked connexons, and the role of hemichannel
regulation for the maintenance of bone cell viability and, potentially, bone health.
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INTRODUCTION
The amount of bone and its strength is maintained throughout
life by the concerted actions of osteoblasts, the bone form-
ing cells, and osteoclasts, the bone removing cells (Figure 1A).
The action of these two cell types is coordinated by sig-
nals derived from osteocytes, the bone resident cells that
derived from osteoblasts and are embedded in the bone matrix
(Figures 1A–D). Osteocytes are highly communicated among
themselves and with cells of the bone surface through cytoplasmic
projections (Figure 1C).
The existence of gap junctions between osteocytes and
osteoblasts on the bone surface was first suggested by electron
microscopy observations of calvaria bones from newborn mice
(Weinger and Holtrop, 1974). Although the level of resolution
of the images did not allow for these authors to conclusive
demonstrate the presence of gaps separating the cell surfaces of
osteoblasts and osteocytes, they concluded that the structures
seen were consistent with gap junctions. This was later confirmed
at the ultramicroscopy level by the groups of Doty (1981) and
Marotti (Palumbo et al., 1990). Further studies showed that Cx43
is the most abundant connexin expressed in vitro and in vivo
in all type of bone cells: osteoblasts, osteocytes and osteoclasts
(Schirrmacher et al., 1992; Civitelli et al., 1993; Jones et al., 1993;
Donahue et al., 1995). This is exemplified on a murine bone
section stained for Cx43 (Figure 1D).
The small molecules that are transferred through connexin
channels, and might act as second messengers in bone cells
have not been completely identified (see Stains et al., 2014 for
a recent revision). Second messengers such as ATP and Ca2+
can move from one cell to another through gap junctions, or
can be released to the extracellular media through hemichan-
nels in osteoblastic cells (Jorgensen et al., 1997; Genetos et al.,
2007). In addition, cAMP production induced by parathyroid
hormone requires Cx43 expression in osteoblastic cells (Vander
Molen et al., 1996; Bivi et al., 2011), and Cx43-mediated amplifi-
cation of FGF2 effect on the osteoblast gene RUNX2 depends on
the production of water-soluble inositol polyphosphates (Niger
et al., 2013). Taken together, these pieces of evidence suggest that
Cx43 not only can control the movement of second messengers,
but also their synthesis.
The expression of Cx45, Cx46 and, more recently, Cx37 has
also been demonstrated in bone cells (Kruger et al., 2000; Stains
and Civitelli, 2005; Paic et al., 2009; Chaible et al., 2011; Pacheco-
Costa et al., 2014). In particular, Cx37 is required for osteoclast
differentiation andmice lacking Cx37 exhibit high bone mass due
to defective bone resorption (Pacheco-Costa et al., 2014).
In addition to be part of gap junctions, connexin channels
can be found in unopposed cell membranes forming undocked
connexons or hemichannels. Although it was long known that
bone cells express connexins, the presence of hemichannels in
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FIGURE 1 | Cell-to-cell interactions among osteoclasts, osteoblasts,
and osteocytes in close proximity maintain bone homeostasis. (A) An
osteoclast (Oc), a team of osteoblasts (Ob) and bone-embedded
osteocytes (Ot) are shown in a rat bone section, in which osteoclasts were
stained for the osteoclast-specific enzyme tartrate resistant acid
phosphatase (TRAPase) (red) and counterstained using Toluidine blue.
Scale bar indicates 50μm. Picture contributed by Keith W. Condon (Indiana
University School of Medicine). (B) Transmission electron microscope
image of an osteocyte embedded in the bone matrix. Image was obtained
at the Electron Microscopy Center of the Department of Anatomy and Cell
Biology (Indiana University School of Medicine). Scale bar indicates 5μm
(C) Scanning electron microscope image of an acid-etched bone showing
two osteocytes highly communicated through their cytoplasmic projections
(Bellido et al., 2014). Scale bar indicates 1μm. (D) Cx43 immunostaining of
a section of cancellous bone showing osteoblasts (Ob) on the bone surface
and osteocytes (Ot) embedded in the bone matrix stained for Cx43 (brown)
and counterstained with Methyl green (Plotkin et al., 2008). Scale bar
indicates 50μm.
osteoblastic cells was not reported until 2001 (Romanello and
D’Andrea, 2001). In the current review, the demonstration of the
presence and function of connexin hemichannels in osteoblasts
and osteocytes is discussed.
Cx43 AND BONE DEVELOPMENT: A ROLE FOR
HEMICHANNELS?
The importance of Cx43 expression in osteoblasts and osteocytes
for bone development, as well as for osteoblast and osteocyte dif-
ferentiation, survival and function has been clearly established
(for recent reviews see Civitelli, 2008; Loiselle et al., 2013; Plotkin
and Bellido, 2013). Thus, global deletion of Cx43 results in
delayed ossification and impaired osteoblast differentiation in the
embryos (Lecanda et al., 2000). In addition, studies with tissue
specific deletion of Cx43 have demonstrated that the adult skele-
ton is also affected by the absence of the connexin (Chung et al.,
2006; Watkins et al., 2011; Zhang et al., 2011; Bivi et al., 2012a,b).
Cx43 is also important for osteoclast differentiation, as demon-
strated in mice in which the connexin was deleted from osteoclast
precursors (Sternlieb et al., 2012). Because these studies were per-
formed by deleting the whole Cx43 molecule, it is not possible to
determine whether absence of cell-to-cell gap junction communi-
cation or the function of Cx43 in undocked hemichannels present
in cell membranes (or even channel-independent functions of the
connexin), or a combination of these functions, are responsible
for the observed phenotypes. Nevertheless, recent developments
discussed below support the presence and functionality of Cx43
hemichannels in bone cells in vivo.
Mutations of the Cx43 gene are associated with occuloden-
todigital dysplasia (ODDD), a condition with skeletal malforma-
tion that include craniofacial abnormalities and broad long bones
(Paznekas et al., 2002). Interestingly, some of the Cx43 muta-
tions leading to ODDD result not only in decreased gap junc-
tion communication, but also in enhanced hemichannel activity
(Dobrowolski et al., 2007), suggesting that part of the phenotype
of the patients might be due to exacerbated hemichannel func-
tion. Consistent with this, a study reported in the form of an
abstract showed that osteocytic expression of the Cx43 mutant
R76W, which does not form gap junctions but has the ability
to form hemichannels, leads to decreased bone mineral density
(Jiang et al., 2010). The phenotype of these mouse models might
be due to the lack of intercellular gap junction communication
or, alternatively, to excessive hemichannel activity in bone cells,
resulting in skeletal defects.
Interestingly, stimuli that increase bone mass have been shown
to increase Cx43 expression, its localization in the cell membrane,
and the activation of gap junction and hemichannel activity.
Thus, estrogen, increases the expression of Cx43 and gap junction
communication in the osteocytic cell line MLO-Y4 (Ren et al.,
2013); and the effect of sex steroid removal on the cortical bone
is partially prevented in mice lacking Cx43 in osteoblastic cells
(Watkins et al., 2012). However, we have shown that the anti-
apoptotic effect of sex steroids on osteocytic cells does not require
Cx43 function (Plotkin et al., 2002). On the other hand, as it
will be discussed below, Cx43, and in particular, hemichannels,
mediate at least in part the effect of the anti-osteoporotic drugs
bisphosphonates (Plotkin et al., 2002, 2008), mechanical stimu-
lation (Cherian et al., 2005; Zhang et al., 2011; Grimston et al.,
2012; Bivi et al., 2013), and parathyroid hormone (Bivi et al.,
2011).
THE BONE PROTECTING DRUGS BISPHOSPHONATES
PRESERVE OSTEOBLAST AND OSTEOCYTE VIABILITY BY
OPENING Cx43 HEMICHANNELS
Bisphosphonates, a family of drugs that include alendronate, have
been used over the past 40 years to treat conditions with low bone
mass such as osteoporosis, and to prevent bone fractures (Russell,
2011). Bisphosphonates block osteoclastic bone resorption, there-
fore preserving the amount of bone. However, stopping bone
resorption cannot completely explain the ability of these drugs to
prevent bone fractures. We therefore proposed that, in addition
to inhibiting bone resorption, bisphosphonates have a positive
effect on osteoblasts and osteocytes that can contribute to the
anti-fracture properties of the drugs. Preservation of osteoblast
life span should lead to prolonged matrix synthesizing activity,
whereas maintenance of osteocyte viability should preserve their
mechanosensory function, therefore improving bone strength.
We found that bisphosphonates protect osteoblasts and osteo-
cytes from apoptosis induced by several agents (Figure 2A) in
vitro using osteoblastic cell isolated from neonatal calvaria bone
and osteocytic MLO-Y4 cells, and by glucocorticoid excess in vivo
using a mouse model of glucocorticoid-induced bone disease
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FIGURE 2 | Schematic representation of the proposed intracellular
signaling pathways regulated by Cx43 hemichannels in bone cells. (A)
Bisphosphonates bind to phosphatases present in the cell membrane. This
induces Cx43 hemichannel opening, followed by activation of the kinases Src
and MEK, and ERKs. ERKs activated downstream of Cx43 hemichannel
opening are retained in the cytoplasm by a complex formed by βarrestin and
clathrins. This leads to the phosphorylation of the cytoplasmic targets p90RSK,
BAD and C/EBPβ, which results in osteoblast and osteocyte survival. (B)
Mechanical stimulation induces α5β1 integrin engagement and the association
of the integrins with Cx43, by a mechanism that requires the protein 14-3-3θ.
This results in hemichannel opening and the release of PGE2. PGE2, in turn,
activates EP2/4 prostaglandin receptor by an autocrine/paracrine mechanism,
leading to activation of the cAMP/PI3K signaling pathways, accumulation of
βcatenin with the consequent activation of Wnt signaling, and inhibition of
osteocyte apoptosis. (C) Parathyroid hormone (PTH), through binding to the
PTH receptor, induces activation of the cAMP/PKA signaling pathway. Cx43, by
sequestering β-arrestin away from the PTH receptor, facilitate
cAMP/PKA-mediated downstream signaling and osteoblast survival.
(Plotkin et al., 1999). Although osteoblasts and osteocytes have
distinct functions, they respond in similar fashion to bisphos-
phonates. Therefore, the studies described in this section were
performed with both cell types.
The survival effect of bisphosphonates is mediated by the acti-
vation of the extracellular signal regulated kinases ERKs in cell
cultures and in vivo (Figure 2A) (Plotkin et al., 1999, 2011).
Thus, phosphorylation of ERKs is increased upon treatment of
cells or mice with the bisphosphonate alendronate. Importantly,
ERK activation is required for the protective effect of bisphospho-
nates since their effect was abolished by ERK pharmacological
inhibitors and by transfection of a dominant negative form of
MEK, the kinase that activates ERKs (Plotkin et al., 1999, 2002).
ERKs can be activated by an array of extracellular stim-
uli, including binding of growth factors and cytokines to their
receptors. We then explored the possibility that bisphosphonates
activate ERKs by acting on membrane channels. Because con-
nexin channels are abundant in osteoblasts and osteocytes, and
bisphosphonates are molecules of low molecular size (approxi-
mately 400 daltons), we examined whether inhibition of connexin
channels affected the protective response to the bisphosphonate
alendronate. We found that inhibiting connexin channels with 18
α-glycyrrhetinic acid (AGA) abolished the anti-apoptotic effect of
alendronate, whereas the inactive analog of AGA, glycyrrizic acid
(GA), did not modify this response (Plotkin et al., 2002). Similar
to anti-apoptosis, AGA, but not GA, prevented ERK activation
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induced by alendronate. These results suggested that the con-
nexin channels are required for the ERK-mediated anti-apoptotic
effect of bisphosphonates. However, prevention of apoptosis by
alendronate does not require cell-to-cell contact, since the bis-
phosphonate inhibited apoptosis in cells plated at low density
or maintained in suspension, suggesting that gap junctions do
not mediate the effect of bisphosphonates and that hemichan-
nels are involved. Moreover, treatment with alendronate did not
affect gap junction communication. Instead, alendronate induced
opening of hemichannels in MLO-Y4 cells measured as uptake
of the fluorescent small dye Lucifer Yellow. Because Cx43 is the
main connexin protein expressed in osteocytic MLO-Y4 cells, we
next determined whether responsiveness to alendronate depends
on its expression using several cell models (Plotkin et al., 2002).
We found that the drug was able to protect from apoptosis
embryonic fibroblasts derived from wild type mice, but it was
unable to do so in cells derived from Cx43 deficient mice, and
that transfecting Cx43 to deficient cells rescued responsiveness to
alendronate. Similarly, ROS17/2.8 osteoblastic cells that express
Cx43 were protected from apoptosis by alendronate, but UMR
106 cells which do not express Cx43 were not. And Cx43 trans-
fection to UMR106 cells rescued responsiveness to alendronate.
Moreover, authentic osteoblasts derived from Cx43 deficient mice
did not respond to alendronate, whereas apoptosis was prevented
by this agent in osteoblasts derived from wild type mice. Cx43,
but not other connexins tested as representative of the three
connexin subfamilies (26, 31, 32, 37, 40, and 45), was able to
confer responsiveness to alendronate in HeLa cells, which do
not express connexins (Plotkin et al., 2002). These results estab-
lished the requirement of Cx43 for the anti-apoptotic effect of
bisphosphonates in vitro.
The cytoplasmic C-terminal domains of connexins differ con-
siderably, suggesting that the specific requirement of Cx43 for the
effect of alendronate could be due to this region. Indeed, a Cx43
truncated mutant that lacks the cytoplasmic tail was unable to
confer responsiveness to alendronate, response that was recov-
ered by co-transfecting the truncated mutant and the cytoplasmic
tail (Plotkin et al., 2002). However, the C-terminus tail alone
was not able to mediate anti-apoptosis. These results suggest
that the C-terminus of Cx43 contains domains required for anti-
apoptosis by bisphosphonates and that the pore-forming region
also contributes to the effect.
Further studies showed that bisphosphonates induce the tran-
sient opening of undocked Cx43 hemichannels resulting in acti-
vation of Src kinase, which is associated with Cx43, leading to
ERK activation and cell survival (Figure 2A) (Plotkin et al., 2002).
Since receptors for bisphosphonates have not been described, the
requirement of Cx43 for bisphosphonate actions raised the possi-
bility that Cx43 would be such receptor. However, we found that
bisphosphonates not only bind to cells that express Cx43 but also
to Cx43-deficient cells (Lezcano et al., 2012). Moreover, bind-
ing of labeled bisphosphonate to osteoblastic cells is displaced
by unlabeled bisphosphonates, as expected, but also by protein
phosphatase substrates. Furthermore, these substrates inhibit the
anti-apoptotic effect of bisphosphonates (Morelli et al., 2011)
Changes in the phosphorylation status of Cx43 C-terminus tail
are associated with channel activity (reviewed in Herve and
Sarrouilhe, 2006), suggesting that bisphosphonates might induce
opening of Cx43 hemichannels thought their interaction with
membrane bound phosphatases. However, the identity of the
protein phosphatase that binds to Cx43, and whether it can
dephosphorylate Cx43 and induce hemichannel opening remain
to be determined. Taken together, these pieces of evidence indi-
cate that although Cx43 is required for survival signaling, it is
dispensable for bisphosphonate binding; and raises the possibility
that bisphosphonates bind to a protein phosphatase that interact
with Cx43 in the cell membrane.
An interesting feature of ERKs activated by bisphosphonates
and the Cx43/Src pathway is that instead of undergoing nuclear
translocation like ERKs activated by most stimuli, they are
retained in the cytoplasm where ERKs modify cytoplasmic sub-
strates (Plotkin et al., 2005a). We found that this phenomenon is
due to the ability of Cx43 of interacting with β-arrestins (Plotkin
et al., 2006b). Consistent with a role of β-arrestin in the reten-
tion of bisphosphonate-activated ERKs in the cytoplasm, ERKs
stay in the cytoplasm in cells expressing endogenous β-arrestin
or transfected with wild type β-arrestin. However, in the pres-
ence of a dominant negative from of β-arrestin, ERKs activated
by alendronate translocate to the nucleus. Because cytoplasmic
localization of ERKs is required for survival induced by bisphos-
phonates (Plotkin et al., 2005a), the dominant negative β-arrestin
reversed anti-apoptosis induced by alendronate. Thus, Cx43 reg-
ulates the ERK signaling pathway due to its ability of function as a
scaffold that foster interaction between β-arrestin and Src/ERKs.
Further support for the role of Cx43 on the survival effect of
bisphosphonates was obtained in vivo, by the demonstration that
administration of alendronate does not prevents glucocorticoid-
induced osteoblast and osteocyte apoptosis in mice lacking Cx43
in these cells (Plotkin et al., 2008). However, the bisphospho-
nate was still able to prevent bone loss induced by glucocorticoids
due to its potent inhibition of bone resorption. Similarly, bispho-
sphonates prevented bone loss induced by sex steroid removal
in mice lacking Cx43 in osteoblasts and osteocytes, by reduc-
ing bone resorption (Watkins et al., 2012). On the other hand,
IG9402, a bisphosphonate that does not affect osteoclast function
by prevents osteoblast and osteocyte apoptosis, prevents bone loss
induced by glucocorticoids in mice (Plotkin et al., 2006a, 2011).
This suggest that in the absence of anti-resorptive effects, the
protective effect of preventing osteocyte and osteocyte apopto-
sis through opening Cx43 hemichannels can be revealed. Thus,
preservation of osteoblast and osteocyte apoptosis mediated by
hemichannel opening might contribute to the anti-fracture effi-
cacy of bisphosphonates.
MECHANICAL STIMULATION OPENS Cx43 HEMICHANNELS
IN VITRO, A MECHANISM THAT MEDIATES CELL SURVIVAL
INDUCED BY MECHANICAL FORCES
Adequate mechanical stimulation is required for maintaining
bone mass and strength throughout life. Indeed, reduced or
absent loading leads to decrease bone mass and elevated risk of
fractures in the elderly, in immobilized patients, and in astronauts
(Bikle et al., 1997; Marcus, 2002; Dolbow et al., 2011). Osteocytes
are ideally positioned for detecting and responding to changes
in mechanical strains imposed on bone. Since their description
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at the microscopy level, connexin channels were thought to be
the means by which the cells buried in the bone communicate
with the cells on the bone surface and transmit the need for bone
formation or removal.
Consistent with a role of connexin channels onmechanotrans-
duction in bone, Cx43 expression and intercellular communica-
tion is increased by loading in vitro and in vivo (Ziambaras et al.,
1998; Cheng et al., 2001b; Robinson et al., 2006; Tu et al., 2012).
Early work by Donahue’s group show that mechanical stimula-
tion of osteoblastic cells induced by oscillatory fluid flow leads to
release of prostaglandin (PG) E2 by a mechanism that requires
intact Cx43 channels (Figure 2B) (Saunders et al., 2001). Thus,
the release of PGE2 was inhibited in cells expressing a domi-
nant negative form of Cx43 with reduced channel permeability.
Moreover, PGE2 release induced by mechanical stimulation fur-
ther increased gap junction communication (Cheng et al., 2001a)
by a mechanism mediated by the prostaglandin EP2 receptor
(Cherian et al., 2003) suggesting the existence of a positive
feedback loop. This effect of mechanical loading was originally
ascribed to a role of Cx43 in intercellular gap junction communi-
cation. However, based on previous studies showing that mechan-
ical stimulation increases hemichannel opening in osteoblastic
cells in vitro (Romanello et al., 2003), work from Jiang’s group
demonstrated that PGE2 released induced by mechanical stim-
ulation requires opening of Cx43 hemichannels in osteocytic
cells (Figure 2B) (Cherian et al., 2005). Interestingly, hemichan-
nels present in the osteocytic cell body, and not in the dendritic
cytoplasmic projections, are opened by mechanical stimulation
(Burra et al., 2010). The release of PGE2 induced by fluid flow in
osteocytic MLO-Y4 cells was prevented by using pharmacologic
inhibitors of connexin channels and by an anti-sense oligonu-
cleotide for Cx43 (Cherian et al., 2005). Moreover, prostaglandin
release was enhanced when the cells were seeded at low den-
sity, which reduces intercellular gap junction communication.
Intracellular levels of PGE2 production were not affected by inhi-
bition of connexin channels, suggesting that PGE2 release but not
its synthesis requires Cx43 hemichannel activity. Other authors
have postulated, however, that P2X7 receptors (Li et al., 2005)
and/or pannexin1 (Thi et al., 2012) are involved in the release
of PGE2 induced by mechanical stimulation in bone cells. This
suggests that the combined actions of these channels are required
for prostaglandin release induced by mechanical stimulation in
osteoblastic and osteocytic cells.
Further studies by Jiang’s group demonstrated that engage-
ment of α5β1 integrin in required for opening of Cx43 hemichan-
nels in osteocytic cells (Figure 2B) (Batra et al., 2012). Thus,
Cx43 interacts with α5β1 integrin, an interaction enhanced by
mechanical stimulation (Batra et al., 2012, 2014). Cx43/α5β1
association is required for Cx43 hemichannel opening induced
by loading and is mediated by activation of phosphatidylinositol-
3 kinase (PI3K) and AKT. Consistent with a role of the integrins
on mechanotransduction, we have shown that mechanical stim-
ulation leads to the engagement of integrins α5 and β1, which in
turn activate FAK/Src and the ERK pathway promoting osteocyte
survival (Plotkin et al., 2005b).
More recently, Jiang’s group showed that the scaffolding
molecule 14-3-3θ is required for the interaction between integrin
α5 and Cx43 and for plasma membrane delivery and function of
Cx43 hemichannels (Figure 2B) (Batra et al., 2013). In particular,
silencing of 14-3-3θ prevents the accumulation of Cx43 on the cell
membrane and opening of hemichannels induced by fluid flow.
Taken together, these studies support a role of Cx43 hemichannels
on PGE2 release.
PGE2 release by osteocytes through Cx43 hemichannels sub-
jected to mechanical forces is required for maintaining cell
viability (Figure 2B). Indeed, prostaglandins prevent osteoblas-
tic apoptosis via activation of EP4 receptors (Machwate et al.,
2001); and mechanical stimulation prevents osteocyte apopto-
sis in vitro (Plotkin et al., 2005b; Aguirre et al., 2007; Kitase
et al., 2010). Moreover, inhibition of glucocorticoid-induced
apoptosis by mechanical stimulation is abolished by inhibiting
prostaglandin synthesis using indomethacin (Kitase et al., 2010).
The pro-survival effect of PGE2 release by osteocytes subjected
to mechanical stimulation in mediated by activation of the EP2
and EP4 receptors, via cAMP/PKA signaling pathway. In addi-
tion, the study by Kitase and colleagues showed that activation
of Wnt/βcatenin signaling downstream of PI3K/Akt contributes
to PGE2/EP2/4-induced osteocyte survival (Figure 2B).
The participation of the Cx43/PGE2 survival pathway in skele-
tal homeostasis in vivo is not known. However, this potential role
of Cx43 is supported by our work (Plotkin et al., 2008; Bivi et al.,
2012a), later confirmed by others (Lloyd et al., 2013) showing that
deletion of Cx43 from osteoblastic cells results in increased osteo-
cyte apoptosis. Interestingly, recent work from Jiang’s group (Xu
et al., 2013) showed that transgenic mice expressing in osteocytes
a dominant negative Cx43 mutant with impaired permeability
(Cx43130-136), which lacks both hemichannel and gap junc-
tion functions (Krutovskikh et al., 1998), also exhibit increased
osteocyte apoptosis (Jean X. Jiang, personal communication). On
the other hand, mice with osteocytic expression of the R76W
Cx43 mutant, in which the ability to form gap junction channels
is impaired, but that maintains hemichannel activity (Xu et al.,
2013) did not exhibit increased osteocyte apoptosis compared
to wild type controls (Jean X. Jiang, personal communication).
This evidence supports the role of Cx43 hemichannels for main-
tain osteocyte survival in vivo; and suggests that in the absence
of Cx43 hemichannels in osteocytes, the mechanical loading that
occurs during normal ambulatory conditions cannot protect the
cells from undergoing apoptosis. Indeed, one of the earliest effects
of skeletal unloading is the accumulation of apoptotic osteocytes
(Aguirre et al., 2006).
However, Cx43 is not required for the increased bone mass
induced by mechanical stimulation in murine models. On the
contrary, removal of Cx43 from osteoblasts and/or osteocytes
results in increased anabolic response to mechanical stimula-
tion of osteoblast on the periosteal bone surface (Zhang et al.,
2011; Grimston et al., 2012; Bivi et al., 2013). The cause of this
exacerbated response is not known. We have found that Cx43-
deficient osteocytes exhibit elevated Wnt/βcatenin signaling (Bivi
et al., 2013), a known mediator of mechanical signals in osteo-
cytes (Robinson et al., 2006). This higher basal activation of
Wnt signaling could explain the exacerbated response to loading
in Cx43-deficient mice. Nevertheless, mounting evidence indi-
cates that Cx43 hemichannel opening and the release of PGE2
mediate the survival effect of mechanical stimulation on osteo-
cytes, suggesting that the increase in bone formation induce by
www.frontiersin.org April 2014 | Volume 5 | Article 131 | 5
Plotkin Cx43 hemichannels and bone
mechanical stimulation depends on signaling pathway different
from those involved in loading-induced osteocyte survival.
Cx43 EXPRESSION AND CHANNEL PERMEABILITY BUT NOT
GAP JUNCTION CHANNELS ARE REQUIRED FOR
cAMP-MEDIATED ANTI-APOPTOTIC EFFECT OF
PARATHYROID HORMONE ON OSTEOBLASTS
Intermittent administration of parathyroid hormone (PTH) is
the only FDA-approved treatment to increase bone mass. Cx43
expression appears to be required to obtain a full anabolic
response to intermittent PTH administration in mice (Castro
et al., 2003; Chung et al., 2006). Thus, PTH does not increase
bone mass, bone formation and osteoblast number when admin-
istered to heterozygous Cx43 deficient mice (Cx43+/−) (Castro
et al., 2003). Moreover, PTH-induced mineral appositional rate,
a measure of the work of osteoblast teams, is reduced in mice
lacking Cx43 in osteoblastic cells (in Cx43fl/−; Col1a1-2.3kb-Cre
mice) (Chung et al., 2006). Studies in mice have shown that the
anabolic effect of intermittent PTH administration in cancellous
bone is due, at least in part, to inhibition of osteoblast apopto-
sis (Figure 2C) (Jilka et al., 1999). Similarly, PTH related protein
(PTHrP), the other ligand of the PTH receptor, as well as consti-
tutive activation of this receptor in transgenic mice, also increases
osteoblast number and decreases the prevalence of osteoblast
apoptosis (Calvi et al., 2001; Martin, 2005; Miao et al., 2005;
O’Brien et al., 2008). Taken together, these pieces of evidence sug-
gest that intermittent PTH administration does not result in a full
anabolic response in mice lacking Cx43 due to the inability of the
hormone to prevent apoptosis of osteoblastic cells in the absence
of Cx43.
In vitro mechanistic studies showed that, indeed, PTH does
not prevent apoptosis in osteoblastic cells lacking Cx43, whereas
overexpression of wild type Cx43 rescues the survival effect of
the hormone (Figure 2C) (Bivi et al., 2011). A similar result
is obtained by transfecting a Cx43 mutant in which cysteine
residues of the extracellular domain have been mutated, render-
ing it unable to dock with other connexin molecules to form gap
junction channels (Bao et al., 2004). On the other hand, a Cx43
mutant with impaired permeability was not able to confer respon-
siveness to PTH, suggesting that active Cx43 hemichannels are
required for the survival effect of the hormone.
In addition, the interaction of Cx43 with β-arrestin modu-
lates the response of osteoblasts to PTH (Figure 2C) (Bivi et al.,
2011). Thus, PTH-induced anti-apoptosis is rescued by transfect-
ing a dominant negative form of β-arrestin to cells lacking Cx43;
and overexpression of β-arrestin induces the same inhibition on
PTH-induced osteoblast survival as removing Cx43. Moreover,
transfection of Cx43 decreases the association between the PTH
receptor and β-arrestin, suggesting that Cx43 binds to β-arrestin,
thus competing with the PTH receptor. Interestingly, Cx43
mutants lacking the C-terminus domain or lacking the phos-
phorylation site in serine 368 decrease the interaction between
PTHR and β-arrestin, suggesting that Cx43 binds β-arrestin at the
phosphorylated serine 368.
We found that PTH does not increase the expression of cAMP-
target genes in osteoblastic cells lacking Cx43 (Bivi et al., 2011).
Consistent with this, it was previously shown that the response
to PTH on cAMP production is blunted in osteoblastic cells in
which Cx43 expression has been reduced using anti-sense cDNA
(Vander Molen et al., 1996). These findings, together with evi-
dence that β-arrestin reduces cAMP responses of the PTH recep-
tor (Premont and Gainetdinov, 2007), support the hypothesis
that Cx43 interacts with β-arrestin decreasing β-arrestin binding
to the PTH receptor, then facilitating cAMP dependent signaling
induced by PTH. Thus, Cx43 hemichannel activity and the ability
of the connexin to interact with intracellular signaling molecules,
through specific phosphorylation sites in its cytoplasmic tail,
regulates survival signaling induced by PTH in osteoblastic cells.
CONCLUSIONS
Since the first description of gap junction channels at the struc-
tural level in bone cells, substantial advances on our understand-
ing of the role of connexins on bone cell physiology have been
made (Civitelli, 2008; Loiselle et al., 2013; Plotkin and Bellido,
2013). The requirement of connexins, and in particular Cx43, for
bone cell differentiation and function, as well as for the response
of the cells to bone-acting stimuli has been clearly established
in vitro and in vivo. Moreover, the role of the Cx43 hemichan-
nels in vivo has begun to be unveiled. Indeed, while studies with
genetically modified mice appear to agree that sustained open-
ing of Cx43 hemichannels is deleterious for bone (Dobrowolski
et al., 2007; Jiang et al., 2010), transient opening of hemichannels
is beneficial for osteoblast and osteocyte survival (Plotkin et al.,
2002, 2008, 2011; Kitase et al., 2010; Bivi et al., 2011). Studies
using genetically modified mice currently underway will allow to
conclusively demonstrate the role of Cx43 hemichannels on bone
development and cell function.
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